Smith & Nephew has agreed to pony up $125 million in cash for Rotation Medical, with a potential $85 million to follow.
The takeover gives J&J control of software designed to standardize operations by providing teams with a checklist of best practices.
The complex and intertwined dual epidemics of poorly treated pain and opioid addiction require a combined, artful approach to secure the best possible results…
The deal connects Ionis to the manufacturer of a blood collection device that could simplify mitigation of its drugs’ safety risks.
Boston Scientific forked over $175 million up front for Apama Medical, which is working on a new treatment for afib.
Illumina Ventures reeled in $130 million in new funding, bringing its genomics-ventured fund to $230 million.
Genomics England and Inivata are partnering on a pilot study to evaluate the use of blood plasma in cancer liquid biopsy.
Henry Schein will market Cerebral Assessment Systems' screening device that detects early signs of dementia.
The deal moves Blue Earth a step closer to making its recently approved prostate cancer agent available in its home country.
Having cleared the last regulatory hurdles, Abbott will close its deal to acquire Alere on Tuesday.
Qualcomm outlicensed its single-use, connected biometric patches for the real-time monitoring of patients to Benchmark Electronics.